Albert Bourla, Pfizer CEO (Evan Vucci, AP Images)
March 11, 2022 10:29 AM EST
Coronavirus

Covid-19 roundup: Pfiz­er read­ies FDA ap­pli­ca­tion for fourth dose to deal with Omi­cron

Zachary Brennan

Senior Editor

As hos­pi­tal­iza­tions be­gin to rise again in the UK, Pfiz­er CEO Al­bert Bourla told CN­BC yes­ter­day that the com­pa­ny will soon …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Dan­ish biotech Gubra touts ear­ly weight loss da­ta in hot amylin field

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

J&J takes 340B fight with fed­er­al gov­ern­ment to court

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times